Ironwood Investment Counsel’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-920
Closed -$225K 260
2024
Q3
$225K Buy
+920
New +$206K 0.04% 241
2023
Q3
Sell
-991
Closed -$217K 257
2023
Q2
$217K Sell
991
-184
-16% -$41K 0.05% 194
2023
Q1
$257K Buy
1,175
+65
+6% +$14.1K 0.06% 177
2022
Q4
$231K Buy
1,110
+2
+0.2% +$439 0.06% 185
2022
Q3
$241K Buy
1,108
+2
+0.2% +$455 0.07% 160
2022
Q2
$231K Buy
1,106
+2
+0.2% +$426 0.06% 173
2022
Q1
$267K Buy
1,104
+202
+22% +$48.9K 0.07% 167
2021
Q4
$235K Buy
902
+1
+0.1% +$259 0.05% 184
2021
Q3
$237K Buy
901
+1
+0.1% +$273 0.06% 173
2021
Q2
$222K Buy
+900
New +$189K 0.06% 187
2021
Q1
Sell
-1,990
Closed -$423K 215
2020
Q4
$423K Buy
1,990
+222
+13% +$44.3K 0.1% 148
2020
Q3
$303K Buy
1,768
+4
+0.2% +$739 0.08% 155
2020
Q2
$339K Buy
1,764
+4
+0.2% +$654 0.1% 138
2020
Q1
$259K Buy
1,760
+5
+0.3% +$796 0.1% 136
2019
Q4
$272K Sell
1,755
-75
-4% -$10.8K 0.09% 147
2019
Q3
$247K Buy
1,830
+5
+0.3% +$655 0.09% 148
2019
Q2
$222K Buy
+1,825
New +$202K 0.08% 151
2019
Q1
Sell
-1,813
Closed -$206K 158
2018
Q4
$206K Buy
1,813
+6
+0.3% +$643 0.09% 147
2018
Q3
$208K Buy
+1,807
New +$198K 0.08% 146

Other funds holding RMD

Ironwood Investment Counsel's RMD Position: Q4 2024 in Review

Ironwood Investment Counsel sold out of ResMed (RMD) in Q4 2024, closing a stake of 920 shares — an estimated $225K sold.

Ironwood Investment Counsel first reported a position in RMD in Q3 2018 and held it in 19 quarters. The position peaked at $423K in Q4 2020. 872 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Ironwood Investment Counsel reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Ironwood Investment Counsel sold 920 ResMed shares in Q4 2024, an estimated $225K.
  • Ironwood Investment Counsel first reported a position in ResMed in Q3 2018 and held it in 19 quarters.
  • Ironwood Investment Counsel's ResMed position peaked at $423K in Q4 2020.
  • 872 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Ironwood Investment Counsel's 13F filing for Q4 2024, filed 10 Feb 2025.